Most cited papers from Novacta (United Kingdom)
What are the most cited papers from Novacta (United Kingdom)?
The most cited paper from Novacta (United Kingdom) is "Alternatives to antibiotics—a pipeline portfolio review" (Lloyd G. Czaplewski et al., 2016), with 864 citations. Next come "Metabolic engineering of Geobacillus thermoglucosidasius for high yield ethanol production" (280) and "Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement" (245).
Showing 12 of 12 papers. Every paper is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Alternatives to antibiotics—a pipeline portfolio review Lloyd G. Czaplewski et al. · The Lancet Infectious Diseases | 13 Jan 2016 | 864 |
| 2 | Metabolic engineering of Geobacillus thermoglucosidasius for high yield ethanol production R. E. Cripps, Kirstin L. Eley, David J. Leak et al. · Metabolic Engineering | 27 Aug 2009 | 280 |
| 3 | Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement Ian Chopra, Christopher John Schofield, Martin J. Everett et al. · The Lancet Infectious Diseases | 25 Jan 2008 | 245 |
| 4 | Dissecting Structural and Functional Diversity of the Lantibiotic Mersacidin Antony N. Appleyard, Shaila Choi, Daniel M. Read et al. · Chemistry & Biology | May 2009 | 100 |
| 5 | Organization of the genes encoding the biosynthesis of actagardine and engineering of a variant generation system Steven Boakes, Jesús Cortés, Antony N. Appleyard et al. · Molecular Microbiology | 28 Apr 2009 | 66 |
| 6 | Generation of an actagardine A variant library through saturation mutagenesis Steven Boakes, Tania Ayala, Mark A. Herman et al. · Applied Microbiology and Biotechnology | 17 Apr 2012 | 47 |
| 7 | New horizons for host defense peptides and lantibiotics Michael J. Dawson, Richard W. Scott · Current Opinion in Pharmacology | 7 Jul 2012 | 46 |
| 8 | Organization of the biosynthetic genes encoding deoxyactagardine B (DAB), a new lantibiotic produced by Actinoplanes liguriae NCIMB41362 Steven Boakes, Antony N. Appleyard, Jesús Cortés et al. · The Journal of Antibiotics | 2 Jun 2010 | 44 |
| 9 | Antibacterial activity of the novel semisynthetic lantibiotic NVB333 in vitro and in experimental infection models Steven Boakes, Jason Weiss, M. E. Vinson et al. · The Journal of Antibiotics | 18 May 2016 | 30 |
| 10 | Chapter 22 Whole‐Cell Generation of Lantibiotic Variants Jesús Cortés, Antony N. Appleyard, Michael J. Dawson · Methods in enzymology on CD-ROM/Methods in enzymology | 2009 | 29 |
| 11 | Characterisation and identification of the human N+-glucuronide metabolite of cediranib Eva M. Lenz, Michael L. Spear, Christopher R. Drake et al. · Journal of Pharmaceutical and Biomedical Analysis | 30 Mar 2010 | 14 |
| 12 | Chemical Biology: Directing Biosynthesis Antony N. Appleyard · ChemBioChem | 15 Dec 2006 | 0 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.